What this study is
The primary objective of this clinical study is to provide the initial validation for monitoring biomarkers of symptoms and functioning for individuals with frontotemporal lobar degeneration (FTLD) syndromes. Researchers at BioSensics, Johns Hopkins University School of Medicine, and Massachusetts General Hospital will use wearable sensors, computerized speech, psychomotor, and cognitive assessments to create outcome measures and digital biomarkers for FTLD syndromes. Researchers will deploy this digital health solution to monitor 60 patients with FTLD syndromes for 24 months with study visits every 6 months.
Study details
- Sponsor
- BioSensics
- Conditions
- Frontotemporal Lobar Degeneration (FTLD) · Frontotemporal Dementia (FTD) · Corticobasal Degeneration · Corticobasal Syndrome (CBS)
- Enrolling
- 60 people
- Starts
- 2026-11-01
- Est. completion
- 2030-12-15
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 40 Years and overSex ALLHealthy volunteers Not acceptedYou may qualify if
- Male and female participants aged 40 years or older with a clinical diagnosis of possible or probable FTLD syndrome phenotype.
- Participants must be fluent in reading and speaking English and must be capable of providing informed consent based on the principal investigator's judgment.
- Individuals eligible for inclusion must be able to comply with the protocol per the investigator's judgment and must have a caregiver or study partner who is willing and able to assist with all study-related procedures.
You can't join if
- Any neurological, medical, or psychiatric condition that would preclude or confound participation in study activities based on the investigator's judgment.
- Individuals who have a history of frequent falls defined as more than 5 falls per month.
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (2)
2 openJohns Hopkins University School of Medicine
Lutherville, Maryland, United States
- Claudia Waddell · Contact410-502-3290cwaddel4@jh.edu
- Alexander Pantelyat, MD · Principal investigator
Massachusetts General Hospital
Boston, Massachusetts, United States
- Jesse Wang · Contact617-643-2400mghpsp@partners.org
- Anne-Marie Wills, MD,MPH · Principal investigator
Study team
Sponsor
BioSensics
Study ID ReMoTe Study
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.